role of pharmacist in hospital Flashcards
What does a Respiratory Hospital Pharmacist do?
Some roles include: Medicine Optimisation; Inhaler technique evaluation Ward referrals for complex patients High risk medicine monitoring service Outpatient Clinics Patient telephone support clinic Respiratory drug evaluations for new medications to be added to the hospital formulary Clinical audits
Drug-drug Interactions in Asthma/COPD
Patients already on theophylline – careful with aminophylline. infusions
• Drugs that lower potassium
• Theophylline interactions e.g. Lithium, macrolides, smoking
Drug-disease Interactions in Asthma/COPD
Diseases that may be affected by drugs used in
asthma/COPD
Diabetes
Cardiovascular disease (watch potassium)
Hypertension
Prostatic hyperplasia
Glaucoma
Liver disease – reduce theophylline clearance
what are the symptoms of severe acute asthma?
Tachypnea Tachycardia Silent chest Cyanosis Altered consciousness Accessory muscle use Decreased O2 saturation breathlessness
Treatment of Severe Acute Asthma Symptoms
Oxygen - SpO2 of 94-98% • β2 agonist bronchodilators eg. Salbutamol high doses act quickly to relieve bronchospasm with few side effects – salbutamol 2.5mg – 5mg can be given “back to back” can also use repeated doses of inhaler via spacer nebulised route (oxygen-driven) repeat at 15-30 minute intervals can be given IV
• Steroids
Prednisolone 40-50mg for at least 5 days
Reduce mortality, relapses, subsequent hospital admission and
requirement for β2agonist therapy
Earlier they are given, better the outcome
Steroid tablets are as effective as injected steroids, provided they
can be swallowed and retained
Ipratropium Bromide
• greater bronchodilation than a β2agonist alone, leading to a faster recovery
and shorter duration of admission
• 500 micrograms every 4-6 hours (usually QDS)
- Magnesium sulphate
- Bronchodilator when given IV or nebulised (only IV currently recommended)
- 1.2-2g IV infusion over 20 minutes
• Aminophylline
Some patients with near-fatal asthma or life threatening asthma with a poor
response to initial therapy may gain additional benefit from IV aminophylline
Check plasma levels if taking oral theophylline (10 – 20mg/ litre)
• Antibiotics/ Leukotriene Receptor Antagonists eg. Montelukast/
Not indicated in acute asthma
what is a nebuliser?
Converts a solution of a drug into a fine spray Oxygen, compressed air or ultrasonic power is used to break up the liquid drug Delivered through a face mask
what to monitor with severe acute asthma?
PEFR Oxygen saturation (Arterial blood gases if SpO2 <92%) Heart rate Potassium Blood glucose Serum theophylline
what is MART therapy?
Step 3 and above • LABA and ICS in a combination product • Maintenance TWICE daily dose • Same inhaler can be used as reliever • Review treatment plan if use as a reliever regularly
what are side effects of ICS - eg. Beclometasone
Oral candidiasis
• Dysphonia
side effects of Long acting beta-2 agonists
eg. Formoterol
• Cardiovascular
stimulation
• Anxiety
• Tremor
what are the side effects of Leukotriene receptor antagonists
eg. Montelukast
Abdominal pain
• Thirst
• Sleep disturbances
• Headache
what are the advice for ICS?
Patients on prolonged high-dose ICS are at risk of systemic side effects (≥1000 micrograms beclomethasone or equivalent) Issue steroid treatment card Advise healthcare team if fall ill Visit GP if experience symptoms such as worsening fatigue, muscle weakness, loss of appetite, dizziness etc. Reduce dose gradually
treatment for COPD
- SABA or SAMA
- asthmatic - LABA + ICS
- non asthmatic - LAMA ANd LABA
- LAMA + LABA +ICS
what are the advantages of combined inhaler in COPD?
Once or twice daily administration depending on product Less expensive than combined cost Convenience of one inhaler Cannot always use spacer
example of • Phosphodiesterase type-4 inhibitor
and use
Anti-inflammatory; Adjunct to bronchodilators for maintenance treatment
Treatment with roflumilast should only be started by a specialist in respiratory
medicine
Doesn’t reduce decline in lung function
Dose: 500 micrograms OD
Side effects – mainly GI. Causes weight loss - patients should monitor body
weight
Not overly expensive for a new drug (£37.71/ pack) but still restricted by NICE
because of lack of significant evidence and doesn’t reduce mortality